Medical Developments International Limited (ASX:MVP)
Australia · Delayed Price · Currency is AUD 0.4050
0.00 (0.00%)
Jul 10, 2026, 4:10 PM AEST
ASX:MVP Market Cap
ASX:MVP has a market cap or net worth of 45.63 million as of July 10, 2026. Its market cap has decreased by -25.69% in one year.
Market Cap
45.63M
Enterprise Value
30.58M
Revenue
40.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since December 19, 2003, ASX:MVP's market cap has increased from 29.06M to 45.63M, an increase of 57.01%. That is a compound annual growth rate of 2.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 45.63M | -27.03% |
| Dec 31, 2025 | 62.53M | 37.04% |
| Dec 31, 2024 | 45.63M | -30.44% |
| Dec 29, 2023 | 65.59M | -48.65% |
| Dec 30, 2022 | 127.73M | -64.16% |
| Dec 31, 2021 | 356.40M | -23.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vita Life Sciences | 134.32M |
| Little Green Pharma | 57.40M |
| Syntara | 45.12M |
| Peak Processing | 19.73M |
| Vitura Health | 18.56M |
| IDT Australia | 13.68M |
| Epsilon Healthcare | 8.56M |
| Argent BioPharma | 8.00M |